Prevention by testosterone of the intestinal toxicity caused by the antitumor agent 3-deazauridine.
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001372:Aza Compounds / Q000627:therapeutic use; D001835:Body Weight / Q000187:drug effects; D002369:Castration; D004305:Dose-Response Relationship, Drug; D005260:Female; D007410:Intestinal Diseases / Q000139:chemically induced / Q000473:pathology; D007422:Intestines / Q000187:drug effects* / Q000473:pathology; D007939:Leukemia L1210 / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D009336:Necrosis; D011728:Pyridones / Q000009:adverse effects; D012737:Sex Factors; D013739:Testosterone / Q000494:pharmacology*; D014529:Uridine / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001372:Aza Compounds; D011728:Pyridones; D013739:Testosterone; D014529:Uridine